Table 1.
Population characteristic.
| Population characteristic | N (%) |
|---|---|
| PATIENTS | 61 |
|
| |
| Age, y, range (median) | 66 (41-88) |
|
| |
| Male | 51 (84) |
|
| |
| Female | 10 (16) |
|
| |
| Smokers | 47 (77) |
|
| |
| Non-smoking | 14 (23) |
|
| |
| Clinical staging | |
|
| |
| Ta | 28 (46) |
|
| |
| T1 | 18 (30) |
|
| |
| T2 | 4 (6) |
|
| |
| T3 | 5 (8) |
|
| |
| TIS | 6 (10) |
|
| |
| Clinical grading | |
|
| |
| LG | 29 (53) |
|
| |
| HG | 32 (47) |
|
| |
| Clinical subgroups | |
|
| |
| NMIBC | 46 (75) |
|
| |
| MIBC | 15 (25) |
|
| |
| CONTROLS | 33 |
|
| |
| Age, y, range (median) | 65 (54-81) |
|
| |
| Male | 28 (85) |
|
| |
| Female | 5 (15) |
|
| |
| Smokers | 24 (73) |
|
| |
| Nonsmokers | 9 (27) |
Ta, T1, T2, TIS: subgroups, according to tumor stage T (TNM: Tumor Nodules Metastases, 2002r.); NMIBC: non-muscle invasive BC; MIBC: muscle invasive BC; LG: low grade; HG: high grade; n: number of cases; y: years.